Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-03 · accession 0001209191-23-016688 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-07 | 2023-03-04+ | TEVA | Dethlefs Sven | EVP, North America Commercial | M - OptEx | — | +77.4K | 179.3K | +76% | — |
| DM | 2023-03-07 | 2023-03-04+ | TEVA | Dethlefs Sven | EVP, North America Commercial | M - OptEx | $0.00 | -77.4K | 115.6K | -40% | $0 |
| D | 2023-03-07 | 2023-03-03 | TEVA | Dethlefs Sven | EVP, North America Commercial | A - Grant | $0.00 | +99.6K | 99.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-03-04 | M | A | 38,538 | — | 217,850 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 2 | Common | Ordinary Shares | 2023-03-05 | M | A | 24,952 | — | 242,802 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 3 | Common | Ordinary Shares | 2023-03-04 | M | A | 13,931 | — | 179,312 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 4 | Derivative | Restricted Share Units | 2023-03-05 | M | D | 24,952 | $0.00 | 49,905 | D | — · — to — | 24,952 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F6) Restricted share units were granted on March 5, 2021, with 24,952 vested on each of March 5, 2022, March 5, 2023 and March 5, 2024, and 24,953 vesting on March 5, 2025. |
| 5 | Derivative | Restricted Share Units | 2023-03-04 | M | D | 13,931 | $0.00 | 0 | D | — · — to — | 13,931 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F4) Restricted share units were granted on March 4, 2019, with 13,930 vested on each of March 4, 2021 and March 4, 2022, and 13,931 vested on March 4, 2023. |
| 6 | Derivative | Restricted Share Units | 2023-03-03 | A | A | 99,601 | $0.00 | 99,601 | D | — · — to — | 99,601 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F3) Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027. |
| 7 | Derivative | Restricted Share Units | 2023-03-04 | M | D | 38,538 | $0.00 | 115,617 | D | — · — to — | 38,538 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F5) Restricted share units were granted on March 4, 2022, with 33,538 vested on March 4, 2023, 33,538 vesting on each of March 4, 2024 and March 4, 2025, and 38,541 vesting on March 4, 2026. |